DJ Incyte Corp. Stock Outperforms Competitors Despite Losses On The Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Incyte Corp. $(INCY)$ shed 1.27% to $111.36 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.38% to 51,850.55 and the S&P 500 Index falling 0.06% to 7,807.24.
Incyte Corp. closed 16.02% below its 52-week high of $132.60, which the company achieved on July 28th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Alnylam Pharmaceuticals Inc. $(ALNY)$ fell 2.43% to $227.02, Bio-Techne Corp. (TECH) rose 0.14% to $72.56, and BioMarin Pharmaceutical Inc. $(BMRN)$ rose 1.09% to $55.39.
Trading volume (1.5 M) remained 27,643 below its 50-day average volume of 1.5 M.
Data source: Dow Jones Market Data, FactSet. Data compiled October 12, 2026.